View by Year:
Select Year View All 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Interpretation of transplant biopsies and immune responses following Treg cell therapy.
Current opinion in organ transplantation, Dec-2014;19(6):616-20.
Failure to achieve normal metabolic response in non-obese diabetic mice and streptozotocin-induced diabetic mice after transplantation of primary murine hepatocytes electroporated with the human proinsulin gene (p3MTChins).
Transplantation proceedings, 2014 Jul-Aug;46(6):2002-6.
Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immune-mediated fetal demise.
Journal of immunology (Baltimore, Md. : 1950), Feb-15-2014;192(4):1938-45. Epub 2014 Jan 15.
Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, Jan-2014;14(1):27-38. Epub 2013 Nov 13.
Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, Nov-2013;13(11):3010-20. Epub 2013 Sep 18.
Regulatory T-cell therapy in transplantation: moving to the clinic.
Cold Spring Harbor perspectives in medicine, Nov-2013;[epublish]3(11):.
Direct and indirect antigen presentation lead to deletion of donor-specific T cells after in utero hematopoietic cell transplantation in mice.
Blood, May-30-2013;121(22):4595-602. Epub 2013 Apr 22.
Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients.
Transplant international : official journal of the European Society for Organ Transplantation, Dec-2012;25(12):1257-67. Epub 2012 Sep 21.
IRE1Î± induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress.
Cell metabolism, Aug-8-2012;16(2):250-64.
Regulatory T-cell therapy for transplantation: how many cells do we need?
Current opinion in organ transplantation, Aug-2012;17(4):349-54.
CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.
Journal of molecular cell biology, Feb-2012;4(1):11-21. Epub 2011 Dec 14.
Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, Feb-2012;12(2):409-19. Epub 2011 Dec 30.
B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.
Proceedings of the National Academy of Sciences of the United States of America, Oct-11-2011;108(41):E823-32. Epub 2011 Sep 12.
Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950), Aug-15-2011;187(4):2015-22. Epub 2011 Jul 8.
Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.
The Journal of surgical research, Jul-2011;169(1):e69-75. Epub 2011 Apr 5.